Skip to content

Enterprise value at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$28.24B+10.2%
Revvity logo
RevvityRVTY
$12.88B-13.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$8B+4.2%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$13.12B+45.9%
IQVIA logo
IQVIAIQV
$42.75B-2.5%
TEC
Bio-TechneTECH
$8.26B-13.6%

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Calculated from Charles River Laboratories’s reported figures.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's enterprise value?
Charles River Laboratories (CRL) reported enterprise value of $11.37B in Q1 2026.
How has Charles River Laboratories's enterprise value changed year-over-year?
Charles River Laboratories's enterprise value increased by 8.5% year-over-year, from $10.48B to $11.37B.
What is the long-term trend for Charles River Laboratories's enterprise value?
Over 5 years (2020 to 2025), Charles River Laboratories's enterprise value has grown at a -3.4% compound annual growth rate (CAGR), from $14.56B to $12.26B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.